期刊文献+

β-synuclein蛋白原核表达载体的构建与表达

Construction of Prokaryotic Expression Vector of β-Synuclein and Expression in E. coli BL21
下载PDF
导出
摘要 目的构建人β-synuclein基因的原核表达载体,分析其在大肠杆菌中的表达。方法从人脑组织中提取总RNA,用RT-PCR方法获得人β-synuclein基因,克隆至pCUm-T载体中,PCR筛选阳性克隆并测序。将酶切后的目的片段克隆至原核表达载体pGEX-6P-1中,转化大肠杆菌BL21。IPTG诱导后,经SDS-PAGE电泳分析目的蛋白的表达。结果 RT-PCR扩增出人β-synuclein基因,将其亚克隆至pGEX-6P-1构建成重组表达质粒,并在BL21中表达了β-synuclein蛋白。结论成功构建人β-synuclein的原核表达载体,并在大肠杆菌中表达了人β-synuclein融合蛋白,为进一步研究β-synuclein在帕金森病中的作用奠定了良好的基础。 Objective To construct a prokaryotic expression vector of β-synuclein and analyze its expression in E.coli BL21.Methods Total RNA was isolated from human fetal brain tissue.The full-length human β-synuclein cDNA was obtained by RT-PCR and then inserted into pCUm-T vector for sequencing.The target gene fragment was subcloned into pGEX-6P-1 vector correctly and then transformed into E.coli BL21.The expression of β-synuclein was induced with IPTG,and analyzed by SDS-PAGE.Results β-synuclein was amplified by RT-PCR and subcloned into pGEX-6P-1 properly.The recombinant fusion protein was expressed in E.coli BL21.Conclusion The prokaryotic expression vector of β-synuclein has been successfully constructed and expressed in E.coli BL21,providing a foundation for the further study of β-synuclein in Parkinson's disease.
出处 《中国实验动物学报》 CAS CSCD 2010年第6期495-497,共3页 Acta Laboratorium Animalis Scientia Sinica
基金 山东省卫生厅青年基金(2007QW007) 潍坊医学院博士启动基金
关键词 β-synuclein 帕金森病 载体构建 β-synuclein Parkinson's disease Gene expression E.coli
  • 相关文献

参考文献7

  • 1Goedcrt M.Alpha-synuclein and neurodegenerative diseases[J].Nat Rev Neurosci,2001,2(7):492-501.
  • 2Yamin G,Munishkina LA,Karymov MA,et al.Forcing nonamyloidogenic beta-synuclein to fibrillate[J].Biochemistry,2005,44(25):9096-9107.
  • 3Jakes R,Spillantini MG,Goedert M.Identification of two distinct synucleins from human brain[J].FEBS Left,1994,345(1):27-32.
  • 4Wood SJ,Wypych J,Stcavenson S,et al.alpha-synuclein fibrillogenesis is nucleation-dependent.Implications for the pathogenesis of Parkinsen's disease[J].J Biol Chem,1999,274(28):19509-19512.
  • 5Hashimoto M,Rockenstein E,Mante M,et al.beta-synuclein inhibits alpha-synuclein aggregation:a possible role as an antiparkinsonian factor[J].Neuron,2001,32(2):213-223.
  • 6Windisch M,Hutter-Paier B,Rockenstein E,et al.Development of a nw treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory β-synuclein-derived peptides[J].Mol Neurosci,2002,19(1-2):63-69.
  • 7Fan Y,Limpraserl P,Murray Ⅳ,et al.β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression[J].Hum Mol Genet,2006,15(20):3002-3011.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部